These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 5901568)

  • 1. Methyldopa in hypertension.
    Br Med J; 1966 Jan; 1(5480):119-20. PubMed ID: 5901568
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of guanethidine and methyldopa in essential hypertension: a controlled study.
    Glazer N
    Curr Ther Res Clin Exp; 1975 Mar; 17(3):249-56. PubMed ID: 805019
    [No Abstract]   [Full Text] [Related]  

  • 3. The relative efficacy of guanethidine, methyldopa and pargyline as antihypertensive agents.
    Oates JA; Seligmann AW; Clark MA; Rousseau P; Lee RE
    N Engl J Med; 1965 Sep; 273(14):729-34. PubMed ID: 5317954
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of severe hypertension with a combination of methyldopa and guanethidine.
    Datey KK; Nanda NC; Dalvi CP
    J Assoc Physicians India; 1965 Sep; 13(9):707-9. PubMed ID: 5840518
    [No Abstract]   [Full Text] [Related]  

  • 5. Controlled trial of guanethidine and methyldopa in moderate hypertension.
    Tarpley EL
    Curr Ther Res Clin Exp; 1974 Nov; 16(11):1187-96. PubMed ID: 4214653
    [No Abstract]   [Full Text] [Related]  

  • 6. Moderate hypertension: treatment with guanethidine and methyldopa.
    Dunn MI; Freeman J
    Curr Ther Res Clin Exp; 1975 Aug; 18(2):285-94. PubMed ID: 809241
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effect of alpha-methyldopa and guanethidine on hemodynamic shifts in the orthostatic position in patients with arterial hypertension].
    Glezer GA; Moskalenko NP
    Kardiologiia; 1972 Dec; 12(12):55-60. PubMed ID: 4661921
    [No Abstract]   [Full Text] [Related]  

  • 8. [Methyldopa, clonidine and guanethidine in the treatment of hypertension].
    Cottier P; Seiler A
    Ther Umsch; 1976 May; 33(5):326-35. PubMed ID: 1006592
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of arterial hypertension with guanethidine, 1-alpha-methyldopa and pargyline hydrochloride].
    Montoreano F; Abrahim H; Plotquin J
    Prensa Med Argent; 1966 Jun; 53(22):1248-51. PubMed ID: 5968337
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of arterial hypertension with alpha-methyldopa].
    Herteanu H; Bucur V
    Med Interna (Bucur); 1969 Sep; 21(9):1119-26. PubMed ID: 5378243
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of hypertension with methyldopa.
    Johnson P; Kitchin AH; Lowther CP; Turner RW
    Br Med J; 1966 Jan; 1(5480):133-7. PubMed ID: 5322501
    [No Abstract]   [Full Text] [Related]  

  • 12. [Considerations on ambulatory therapy in a group of hypertensive patients].
    Repetto S; Rezzonico A; Gervasini N
    Minerva Med; 1969 Jun; 60(51):2550-4. PubMed ID: 5792420
    [No Abstract]   [Full Text] [Related]  

  • 13. The reversibility of side effects of guanethidine therapy.
    Bauer GE; Hull RD; Stokes GS; Raftos J
    Med J Aust; 1973 May; 1(19):930-3. PubMed ID: 4736691
    [No Abstract]   [Full Text] [Related]  

  • 14. [Autocontrol of blood pressure in severe hypertension?].
    Magnus KE
    Ned Tijdschr Geneeskd; 1972 Sep; 116(40):1772-7. PubMed ID: 5069860
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of guanethidine and methyldopa on a standardized test for renin responsiveness.
    Lowder SC; Liddle GW
    Ann Intern Med; 1975 Jun; 82(6):757-60. PubMed ID: 1138585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antihypertensive action of 4 drugs inhibiting the sympathetic nervous system. Preliminary hemodynamic study].
    Weiss Y; Merceron R; Safar M; Milliez P
    Coeur Med Interne; 1973; 12(3):425-9. PubMed ID: 4733293
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacology update: hypotensive agents. Part II: Antiadrenergic agents.
    Romankiewicz JA
    J Pract Nurs; 1979 Aug; 29(8):13-5. PubMed ID: 257005
    [No Abstract]   [Full Text] [Related]  

  • 18. [A controlled blind study of 4 antihypertensive agents (methyldopa and 3 sympatholytic agents)].
    Vejlsgaard V; Christensen M; Clausen E
    Ugeskr Laeger; 1967 May; 129(19):635-8. PubMed ID: 4877293
    [No Abstract]   [Full Text] [Related]  

  • 19. Urinary 5-hydroxyindoleacetic acid in cases of hypertension before and after therapy with guanethidine and methyldopa.
    Nath K; Agarwal SN; Mittal HS; Singh KN; Saxena S; Pant H
    J Indian Med Assoc; 1972 Apr; 58(7):242-5. PubMed ID: 4537955
    [No Abstract]   [Full Text] [Related]  

  • 20. Beta receptor antagonism in hypertension; comparison with the effect of adrenergic neurone inhibition on cardiovascular responses.
    Prichard BN; Gillam PM; Graham BR
    Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):131-40. PubMed ID: 4924319
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.